US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Regeneron Pharmaceuticals

585.21

+23.724.22%

Volume:399.62K

Turnover:231.62M

Market Cap:62.63B

PE:15.26

High:587.10

Open:565.50

Low:565.21

Close:561.49

Loading ...

Overview Company News Filings

Wolfe Research Adjusts Regeneron Pharmaceuticals PT to $950 From $1,000, Keeps Outperform Rating

MT Newswires Live

BUZZ - Nasdaq top and bottom performing stocks at about 11:01 a.m. EDT on 2025-04-21

Regeneron's FDA Setback on Eylea HD Dosing 'No Biggie,' Says Oppenheimer

MT Newswires Live

Regeneron CRL for Eylea extension not surprising, says Oppenheimer

Regeneron receives complete response letter for Eylea extended dosing

Sanofi & Regeneron's Dupixent Receives FDA Nod for Urticaria

Sector Update: Health Care

MT Newswires Live

Analysts Offer Insights on Healthcare Companies: Regeneron (REGN) and Surgery Partners (SGRY)

FDA Approves Dupixent for Chronic Hives in Patients Unresponsive to Antihistamines

MT Newswires Live

Regeneron Pharmaceuticals Says FDA Rejects Bid for Extended Eye Drug Dosing Intervals

MT Newswires Live

Regeneron announces FDA accepted Priority Review sBLA for EYLEA HD

Regeneron to Reassess Strategy for Retinal Condition Treatment After FDA Rejects Dosing Plan

Regeneron Provides Update on Eylea Hd® (Aflibercept) Injection 8 Mg Supplemental Biologics License Application

THOMSON REUTERS

Regeneron Pharmaceuticals Inc - Crl Does Not Identify Safety or Efficacy Issues With Eylea Hd

THOMSON REUTERS

Regeneron Provides Update on EYLEA HD® (aflibercept) Injection 8 mg Supplemental Biologics License Application

BRIEF-Dupixent Approved In US As First New Targeted Therapy In Over Decade For Chronic Spontaneous Urticaria

Regeneron, Sanofi Get FDA Approval For Dupixent in Skin Disease CSU

Sanofi-Regeneron's Dupixent gets FDA's nod for skin condition

Press Release: Dupixent approved in the US as the first new targeted therapy in over a decade for chronic spontaneous urticaria

Dupixent® (dupilumab) Approved in the U.S. as the First New Targeted Therapy in Over a Decade for Chronic Spontaneous Urticaria (CSU)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/REGN/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"REGN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"REGN\",,,,,undefined,":{"symbol":"REGN","market":"US","secType":"STK","nameCN":"Regeneron Pharmaceuticals","latestPrice":585.21,"timestamp":1745341572733,"preClose":561.49,"halted":0,"volume":399618,"delay":0,"floatShares":103007863,"shares":107024682,"eps":38.34,"marketStatus":"Trading","change":23.72,"latestTime":"04-22 13:06:21 EDT","open":565.5,"high":587.1,"low":565.21,"amount":231621729.8013,"amplitude":0.038986,"askPrice":585.82,"askSize":51,"bidPrice":585.02,"bidSize":10,"shortable":3,"etf":0,"ttmEps":38.34,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1745352000000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":561.49,"preHourTrading":{"tag":"盘前","latestPrice":550,"preClose":561.49,"latestTime":"09:24 EDT","volume":168,"amount":95014.1304,"timestamp":1745328295705},"postHourTrading":{"tag":"盘后","latestPrice":564,"preClose":561.49,"latestTime":"19:59 EDT","volume":78782,"amount":44237654.93,"timestamp":1745279949796},"volumeRatio":0.848097,"impliedVol":0.481,"impliedVolPercentile":0.948},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"REGN\",,,,,undefined,":{"symbol":"REGN","floatShares":103007863,"roa":"7.31%","roe":"15.95%","lyrEps":40.895273,"volumeRatio":0.848097,"shares":107024682,"dividePrice":3.52,"high":587.1,"amplitude":0.038986,"preClose":561.49,"low":565.21,"week52Low":525.99,"pbRate":"2.13","psRate":"4.41","week52High":1211.2,"institutionHeld":0.8855,"latestPrice":585.21,"committee":-0.672131,"eps":38.34,"divideRate":0.006015,"volume":399618,"delay":0,"ttmEps":38.34,"open":565.5,"prevYearClose":712.33,"prevWeekClose":563.16,"prevMonthClose":634.23,"prevQuarterClose":634.23,"fiveDayClose":571.06,"twentyDayClose":661,"sixtyDayClose":675.79,"earningDate":1745856000000,"earningTime":"盘前"},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"REGN\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2529382313","title":"Wolfe Research Adjusts Regeneron Pharmaceuticals PT to $950 From $1,000, Keeps Outperform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2529382313","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529382313?lang=en_us&edition=fundamental","pubTime":"2025-04-21 23:58","pubTimestamp":1745251118,"startTime":"0","endTime":"0","summary":"Regeneron Pharmaceuticals (REGN) has an average rating of overweight and mean price target of $901.14, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic resea","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PT","REGN"],"gpt_icon":0},{"id":"2529338686","title":"BUZZ - Nasdaq top and bottom performing stocks at about 11:01 a.m. EDT on 2025-04-21","url":"https://stock-news.laohu8.com/highlight/detail?id=2529338686","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529338686?lang=en_us&edition=fundamental","pubTime":"2025-04-21 23:01","pubTimestamp":1745247664,"startTime":"0","endTime":"0","summary":"BUZZ - Nasdaq top and bottom performing stocks at about 11:01 a.m. EDT on 2025-04-21Nasdaq 100 .NDXTop PerformersPercent ChangeNetflix Inc NFLX.OQ+2.9%Microstrategy Inc MSTR.OQ+2.8%Kraft Heinz Co KHC.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250421:nL8N3QZ0SN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1145028129.USD","IE00BD4GTT62.SGD","LU2108987350.USD","STRK","LU2237957811.SGD","LU0949170772.SGD","TSLA","LU1861220033.SGD","NFLX","LU0208291251.USD","KHC","LU1069344957.HKD","BK4559","LU0256863811.USD","LU2362541513.USD","LU1064131342.USD","LU0072461881.USD","LU2362541273.HKD","BK4598","LU1046421795.USD","LU0056508442.USD","BK4604","LU2552382058.USD","IE0034235303.USD","BK4561","LU1720051108.HKD","BK4587","IE00B19Z8W00.USD","MSTR","TEAM","LU2468319806.SGD","LU1066051811.HKD","BK4524","MDLZ","LU0211331839.USD","LU0642271901.SGD","REGN","CEG","LU1003077747.HKD","LU1066051225.USD","BK4532","TSYW.SI","TTD","LU2357305700.SGD","APP","LU0345769631.USD","LU0006306889.USD","BK4099"],"gpt_icon":1},{"id":"2529383125","title":"Regeneron's FDA Setback on Eylea HD Dosing 'No Biggie,' Says Oppenheimer","url":"https://stock-news.laohu8.com/highlight/detail?id=2529383125","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529383125?lang=en_us&edition=fundamental","pubTime":"2025-04-21 22:42","pubTimestamp":1745246537,"startTime":"0","endTime":"0","summary":"The US Food and Drug Administration's rejection of Regeneron Pharmaceuticals' (REGN) bid to extend the dosing interval in the Eylea HD label is \"no biggie,\" Oppenheimer said in a note Monday.Regeneron","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2089984988.USD","REGN","LU1917777945.USD","LU0058720904.USD","LU1974910355.USD","LU0882574055.USD","BK4588","LU2468319806.SGD","HD","LU2023250504.SGD","LU0109394709.USD","LU0320765992.SGD","LU0823416689.USD","BK4139","LU2106854487.HKD","BK4585","LU2362541513.USD","LU0889565916.HKD","LU2362540622.SGD","LU2237438978.USD","LU0053666078.USD","LU0114720955.EUR","OPY","LU0289739699.SGD","BK4127","LU2362541273.HKD"],"gpt_icon":0},{"id":"2529471800","title":"Regeneron CRL for Eylea extension not surprising, says Oppenheimer","url":"https://stock-news.laohu8.com/highlight/detail?id=2529471800","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529471800?lang=en_us&edition=fundamental","pubTime":"2025-04-21 22:10","pubTimestamp":1745244617,"startTime":"0","endTime":"0","summary":"Oppenheimer keeps an Outperform rating on Regeneron (REGN) with a $925 price target after the FDA denied the company’s attempt to extend the dosing...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/regeneron-crl-for-eylea-extension-not-surprising-says-oppenheimer?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/regeneron-crl-for-eylea-extension-not-surprising-says-oppenheimer?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4530","LU0053666078.USD","LU2106854487.HKD","LU0823416689.USD","LU2023250504.SGD","BK4121","LU0320765992.SGD","LU2089984988.USD","LU2362541513.USD","LU0882574055.USD","LU0109394709.USD","LU2362541273.HKD","OPY","LU0757428866.USD","LU1917777945.USD","BK4585","LU2362540622.SGD","LU2468319806.SGD","BK4139","LU0889565916.HKD","BK4588","LU0114720955.EUR","LU1815336091.USD","REGN","LU1974910355.USD","LU2237438978.USD","LU0390134368.USD","BK4127","LU0289739699.SGD","LU0058720904.USD","CRL"],"gpt_icon":0},{"id":"2529807523","title":"Regeneron receives complete response letter for Eylea extended dosing","url":"https://stock-news.laohu8.com/highlight/detail?id=2529807523","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529807523?lang=en_us&edition=fundamental","pubTime":"2025-04-21 21:45","pubTimestamp":1745243126,"startTime":"0","endTime":"0","summary":"Regeneron (REGN) Pharmaceuticals announced on Friday the Food and Drug Administration has issued a complete response letter regarding the supplemen...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/regeneron-receives-complete-response-letter-for-eylea-extended-dosing?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/regeneron-receives-complete-response-letter-for-eylea-extended-dosing?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2362541273.HKD","LU0882574055.USD","LU0109394709.USD","LU0053666078.USD","LU0058720904.USD","LU1974910355.USD","LU2106854487.HKD","LU0889565916.HKD","LU0823416689.USD","BK4585","LU2362540622.SGD","BK4588","LU2362541513.USD","LU0114720955.EUR","LU2237438978.USD","LU0320765992.SGD","LU2089984988.USD","LU1917777945.USD","BK4139","LU2023250504.SGD","REGN","LU2468319806.SGD","LU0289739699.SGD"],"gpt_icon":0},{"id":"2529389778","title":"Sanofi & Regeneron's Dupixent Receives FDA Nod for Urticaria","url":"https://stock-news.laohu8.com/highlight/detail?id=2529389778","media":"Zacks","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529389778?lang=en_us&edition=fundamental","pubTime":"2025-04-21 21:22","pubTimestamp":1745241720,"startTime":"0","endTime":"0","summary":"Sanofi SNY and partner Regeneron REGN announced that the FDA approved Dupixent  for the treatment of chronic spontaneous urticaria  in adults and adolescents aged 12 years and above, who remain symptomatic despite histamine-1  antihistamine treatment.Following the latest FDA nod, Dupixent became the first new targeted therapy to be approved for CSU in more than a decade. The drug is now approved for seven type II inflammatory diseases in the United States.Dupixent is already approved in several countries, including the United States and the European Union, for treating severe chronic rhinosinusitis with nasal polyposis, severe asthma, moderate-to-severe atopic dermatitis, eosinophilic esophagitis, prurigo nodularis and chronic obstructive pulmonary disease.CSU is an inflammatory skin condition, primarily occurring due to type 2 inflammation. This causes sudden and debilitating hives and swelling on the skin, which is mostly inadequately controlled by antihistamine treatment.Year to dat","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/sanofi-regenerons-dupixent-receives-fda-132200561.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","LU2362540622.SGD","LU0823416689.USD","BK4585","IE00BFXG1179.USD","LU1917777945.USD","IE00BN0W2W23.USD","LU1974910355.USD","BK4007","LU2362541513.USD","LU0114720955.EUR","BK4588","JAZZ","BK4533","IE00BN0W2V16.EUR","REGN","LU0889565916.HKD","LU0053666078.USD","LU2106854487.HKD","LU0882574055.USD","LU2468319806.SGD","LU2023250504.SGD","LU2362541273.HKD","BK4532","IE00BN0W2T93.GBP","SNYNF","LU0058720904.USD","KRYS","LU0109394709.USD","SNY","LU2237438978.USD","LU2089984988.USD","LU0289739699.SGD","LU0320765992.SGD"],"gpt_icon":0},{"id":"2529806703","title":"Sector Update: Health Care","url":"https://stock-news.laohu8.com/highlight/detail?id=2529806703","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529806703?lang=en_us&edition=fundamental","pubTime":"2025-04-21 20:50","pubTimestamp":1745239809,"startTime":"0","endTime":"0","summary":"Health care stocks were falling pre-bell Monday, with The Health Care Select Sector SPDR Fund  down 0.6% and the iShares Biotechnology ETF  1.1% lower.Regeneron Pharmaceuticals  shares were down 0.9% after the company said late Friday that the US Food and Drug Administration issued a complete response letter rejecting its request to add extended dosing intervals for Eylea HD injection 8 mg across all approved indications.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","LU2362540622.SGD","LU0823416689.USD","BK4585","LU1917777945.USD","LU1974910355.USD","LU2362541513.USD","LU0114720955.EUR","BK4588","REGN","IBB","LU0889565916.HKD","XLV","LU0053666078.USD","LU2106854487.HKD","BK4581","LU0882574055.USD","LU2468319806.SGD","LU2023250504.SGD","LU2362541273.HKD","LU0058720904.USD","LU0109394709.USD","LU2237438978.USD","LU2089984988.USD","LU0289739699.SGD","LU0320765992.SGD"],"gpt_icon":0},{"id":"2529777298","title":"Analysts Offer Insights on Healthcare Companies: Regeneron (REGN) and Surgery Partners (SGRY)","url":"https://stock-news.laohu8.com/highlight/detail?id=2529777298","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529777298?lang=en_us&edition=fundamental","pubTime":"2025-04-21 19:31","pubTimestamp":1745235102,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Regeneron (REGN – Research Report) and Surgery Partn...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-regeneron-regn-and-surgery-partners-sgry?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-regeneron-regn-and-surgery-partners-sgry?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0889565916.HKD","LU0053666078.USD","BK4185","LU0823416689.USD","LU1917777945.USD","HCSG","LU1974910355.USD","LU2468319806.SGD","LU2237438978.USD","LU0058720904.USD","SGRY","LU0114720955.EUR","LU0320765992.SGD","BK4139","BK4137","LU0109394709.USD","LU2106854487.HKD","BK4588","LU0289739699.SGD","LU0882574055.USD","LU2362540622.SGD","LU2023250504.SGD","LU2089984988.USD","BK4585","LU2362541273.HKD","REGN","LU2362541513.USD"],"gpt_icon":0},{"id":"2529549871","title":"FDA Approves Dupixent for Chronic Hives in Patients Unresponsive to Antihistamines","url":"https://stock-news.laohu8.com/highlight/detail?id=2529549871","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529549871?lang=en_us&edition=fundamental","pubTime":"2025-04-21 18:42","pubTimestamp":1745232126,"startTime":"0","endTime":"0","summary":"Regeneron Pharmaceuticals  and Sanofi  said Friday the FDA approved Dupixent for treating chronic spontaneous urticaria in individuals aged 12 and up who continue to experience symptoms despite antihistamine use.The approval follows phase 3 trials in which Dupixent, used alongside antihistamines, led to greater reductions in itching and hive activity compared to placebo, the companies said.Patients given Dupixent were also more likely to achieve full or near-complete control of their condition after 24 weeks, Regeneron said.The companies added that the reported side effects were consistent with the drug's existing safety profile, with injection site reactions being the most frequent.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1917777945.USD","LU2362541273.HKD","LU0882574055.USD","LU2023250504.SGD","LU2106854487.HKD","LU0889565916.HKD","LU2237438978.USD","BK4585","BK4007","BK4588","BK4139","REGN","LU0320765992.SGD","LU0053666078.USD","IE00BFXG1179.USD","LU0114720955.EUR","LU1974910355.USD","SNY","LU2468319806.SGD","LU2089984988.USD","LU0109394709.USD","LU0823416689.USD","LU0058720904.USD","LU2362540622.SGD","LU2362541513.USD","LU0289739699.SGD"],"gpt_icon":0},{"id":"2529760378","title":"Regeneron Pharmaceuticals Says FDA Rejects Bid for Extended Eye Drug Dosing Intervals","url":"https://stock-news.laohu8.com/highlight/detail?id=2529760378","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529760378?lang=en_us&edition=fundamental","pubTime":"2025-04-21 18:22","pubTimestamp":1745230974,"startTime":"0","endTime":"0","summary":"Regeneron Pharmaceuticals  said late Friday that the US Food and Drug Administration issued a complete response letter rejecting its request to add extended dosing intervals for Eylea HD injection 8 mg across all approved indications.The company said the health agency raised no concerns about the drug's safety or efficacy but declined to approve the extended schedule.The drugmaker said it is reviewing the decision and considering the next steps.Eylea HD is approved to treat wet age-related macular degeneration, diabetic macular edema, and diabetic retinopathy.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0882574055.USD","LU0823416689.USD","LU2237438978.USD","LU2362541513.USD","LU0058720904.USD","BK4588","BK4585","LU0289739699.SGD","LU2089984988.USD","LU2362541273.HKD","LU2468319806.SGD","LU0114720955.EUR","REGN","LU1974910355.USD","LU1917777945.USD","LU0320765992.SGD","LU2362540622.SGD","LU0053666078.USD","BK4139","LU2106854487.HKD","LU2023250504.SGD","LU0889565916.HKD","LU0109394709.USD"],"gpt_icon":0},{"id":"2528741004","title":"Regeneron announces FDA accepted Priority Review sBLA for EYLEA HD","url":"https://stock-news.laohu8.com/highlight/detail?id=2528741004","media":"TipRanks","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528741004?lang=en_us&edition=fundamental","pubTime":"2025-04-19 23:25","pubTimestamp":1745076307,"startTime":"0","endTime":"0","summary":"On April 17, Regeneron  Pharmaceuticals announced that the U.S. Food and Drug Administration has accepted for Priority Review the supplemental Biologics License Application for EYLEA HD Injection 8 mg. The sBLA seeks approval for EYLEA HD for both the treatment of macular edema following retinal vein occlusion, RVO, and for broadening the dosing schedule to include every 4-week dosing across approved indications. The FDA target action date is August 19, 2025, following the use of a Priority Review voucher. The sBLA is supported by data from across the EYLEA HD clinical program, including the Phase 3 QUASAR trial investigating EYLEA HD in RVO.Discover outperforming stocks and invest smarter with Top Smart Score Stocks.Filter, analyze, and streamline your search for investment opportunities using  Tipranks' Stock Screener.Regeneron, Sanofi announce FDA approval of Dupixent for CSU. Regeneron price target lowered to $150 from $170 at Canaccord. Regeneron price target lowered to $547 from ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/regeneron-announces-fda-accepted-priority-152507327.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/regeneron-announces-fda-accepted-priority-152507327.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4588","LU2756315664.SGD","LU0820561818.USD","LU1929549753.HKD","BK4585","LU1778281490.HKD","LU0889565916.HKD","LU0823416689.USD","BK4533","LU0882574055.USD","LU2362541273.HKD","BK4567","BK4550","LU0820561909.HKD","IE00BZ1G4Q59.USD","LU0354030511.USD","LU1974910355.USD","LU2023250504.SGD","HD","LU1093756325.SGD","BK4139","LU0823434583.USD","LU2362540622.SGD","LU1989772923.USD","REGN","LU2237438978.USD","SG9999001440.SGD","LU1069344957.HKD","LU0689472784.USD","LU1989772840.SGD","BK4534","BK4566","LU0820562030.AUD","LU0053666078.USD","LU0320765646.SGD","LU1674673428.USD","LU1551013425.SGD","BK4581","LU1914381329.SGD","LU0058720904.USD","IE00BKVL7J92.USD","LU1496350171.SGD","LU0943347566.SGD","LU2468319806.SGD","LU0868494617.USD","LU0354030438.USD","LU1674673691.USD","LU0289739699.SGD","IE00BWXC8680.SGD","LU0823434740.USD"],"gpt_icon":0},{"id":"2528015169","title":"Regeneron to Reassess Strategy for Retinal Condition Treatment After FDA Rejects Dosing Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2528015169","media":"Dow Jones","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528015169?lang=en_us&edition=fundamental","pubTime":"2025-04-19 03:37","pubTimestamp":1745005020,"startTime":"0","endTime":"0","summary":"Regeneron Pharmaceuticals said it is working to determine a path forward for its treatment of several retinal conditions after the Food and Drug Administration said it didn't agree with the company's proposal to extend the interval between doses.The FDA told Regeneron in a complete response letter that while it didn't identify any issues with the safety or efficacy of the drug in its approved indications and dosing regimens, the agency didn't agree with Regeneron's proposal to add additional extended dosing intervals. The company previously submitted a supplemental biologics license application for the addition of extended dosing intervals of up to 24 weeks for the drug, across all its approved applications.The Tarrytown, N.Y., biotech company said Friday its treatment, Eylea HD, is approved with dosing intervals from every eight to 16 weeks for patients with wet age-related macular degeneration and diabetic macular edema, and every eight to 12 weeks for patients with diabetic retinopa","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4595","LU2237438978.USD","LU2089984988.USD","STRK","LU2362541273.HKD","LU0053666078.USD","BK4139","BK4588","LU0320765992.SGD","LU0058720904.USD","LU1917777945.USD","BK4600","BK4596","BK4023","LU2362540622.SGD","LU2468319806.SGD","BK4585","LU0114720955.EUR","LU0109394709.USD","LU1974910355.USD","LU2023250504.SGD","LU2362541513.USD","LU0889565916.HKD","LU0289739699.SGD","LU0882574055.USD","LU2106854487.HKD","LU0823416689.USD","REGN","BK4516"],"gpt_icon":1},{"id":"2528826013","title":"Regeneron Provides Update on Eylea Hd® (Aflibercept) Injection 8 Mg Supplemental Biologics License Application","url":"https://stock-news.laohu8.com/highlight/detail?id=2528826013","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528826013?lang=en_us&edition=fundamental","pubTime":"2025-04-19 03:00","pubTimestamp":1745002822,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250418:nTUAB2GPFV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0109394709.USD","LU0823416689.USD","BK4585","LU2468319806.SGD","LU0058720904.USD","LU0289739699.SGD","LU2023250504.SGD","REGN","LU0114720955.EUR","LU2106854487.HKD","BK4588","LU0320765992.SGD","LU2237438978.USD","BK4139","LU0882574055.USD","LU2362541273.HKD","LU1917777945.USD","LU0053666078.USD","LU2362540622.SGD","LU0889565916.HKD","LU1974910355.USD","LU2362541513.USD","LU2089984988.USD"],"gpt_icon":0},{"id":"2528013824","title":"Regeneron Pharmaceuticals Inc - Crl Does Not Identify Safety or Efficacy Issues With Eylea Hd","url":"https://stock-news.laohu8.com/highlight/detail?id=2528013824","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528013824?lang=en_us&edition=fundamental","pubTime":"2025-04-19 03:00","pubTimestamp":1745002822,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250418:nTUAB2GPFV:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1917777945.USD","LU2023250504.SGD","BK4585","LU2362541513.USD","LU2106854487.HKD","LU0289739699.SGD","LU1974910355.USD","LU0058720904.USD","LU2089984988.USD","LU0109394709.USD","LU0889565916.HKD","BK4139","LU2362540622.SGD","LU2237438978.USD","LU0114720955.EUR","BK4588","LU0320765992.SGD","LU0882574055.USD","LU2468319806.SGD","REGN","LU2362541273.HKD","LU0823416689.USD","LU0053666078.USD"],"gpt_icon":0},{"id":"2528013715","title":"Regeneron Provides Update on EYLEA HD® (aflibercept) Injection 8 mg Supplemental Biologics License Application","url":"https://stock-news.laohu8.com/highlight/detail?id=2528013715","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528013715?lang=en_us&edition=fundamental","pubTime":"2025-04-19 03:00","pubTimestamp":1745002800,"startTime":"0","endTime":"0","summary":"TARRYTOWN, N.Y., April 18, 2025  -- Regeneron Pharmaceuticals, Inc.  today announced that the U.S. Food and Drug Administration  has issued a complete response letter  regarding the supplemental Biologics License Application  for the addition of extended dosing intervals  for EYLEA HD  Injection 8 mg across all approved indications.EYLEA HD is approved with dosing intervals from every 8 to 16 weeks for patients with wet age-related macular degeneration  and diabetic macular edema , and every 8 to 12 weeks for patients with diabetic retinopathy , following 3 initial monthly doses.About Ophthalmology Development at Regeneron At Regeneron, we relentlessly pursue groundbreaking innovations in eye care science to help maintain the eye health of the millions of Americans impacted by vision-threatening conditions. Our expertise in angiogenesis and decades of research serve as our foundation, fueling our ongoing ambition to further innovate new solutions for patients. Our robust and diverse re","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/regeneron-provides-eylea-hd-aflibercept-190000362.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4530","LU2468319806.SGD","BK4023","LU0082616367.USD","LU1551013425.SGD","LU1951198990.SGD","BK4532","CRL","IE0009356076.USD","IE00BKVL7J92.USD","LU1951200564.SGD","LU0079474960.USD","LU1917777945.USD","LU0868494708.USD","LU1316542783.SGD","ROP","LU0198837287.USD","IE00BQXX3F31.USD","LU2506951958.HKD","LU0109392836.USD","LU0058720904.USD","LU1242518931.SGD","LU1929549753.HKD","BK4612","BK4206","IE00BSNM7G36.USD","IE00BMPRXR70.SGD","SG9999001440.SGD","LU1430594728.SGD","LU2098885051.SGD","BK4533","LU0354030438.USD","LU0889565916.HKD","LU0127658192.USD","LU1778281490.HKD","BK4534","REGN","LU2458330169.SGD","BK4605","LU1303367103.USD","LU2264538146.SGD","LU1880398471.USD","LU1988902786.USD","LU0234572021.USD","BK4581","LU0950375773.USD","BK4575","HD","LU0823411888.USD"],"gpt_icon":1},{"id":"2528092118","title":"BRIEF-Dupixent Approved In US As First New Targeted Therapy In Over Decade For Chronic Spontaneous Urticaria","url":"https://stock-news.laohu8.com/highlight/detail?id=2528092118","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528092118?lang=en_us&edition=fundamental","pubTime":"2025-04-19 01:18","pubTimestamp":1744996715,"startTime":"0","endTime":"0","summary":"BRIEF-Dupixent Approved In US As First New Targeted Therapy In Over Decade For Chronic Spontaneous UrticariaApril 18 (Reuters) - Regeneron Pharmaceuticals Inc REGN.O:DUPIXENT (DUPILUMAB) APPROVED IN T","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250418:nFWN3QV3FN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2106854487.HKD","LU0289739699.SGD","REGN","LU2362541513.USD","LU1974910355.USD","BK4139","LU0320765992.SGD","LU0053666078.USD","LU1917777945.USD","LU2089984988.USD","LU2237438978.USD","LU2362540622.SGD","BK4585","BK4588","LU2362541273.HKD","LU0823416689.USD","LU0109394709.USD","LU0058720904.USD","LU0882574055.USD","LU2468319806.SGD","LU0114720955.EUR","LU0889565916.HKD","LU2023250504.SGD"],"gpt_icon":0},{"id":"2528963660","title":"Regeneron, Sanofi Get FDA Approval For Dupixent in Skin Disease CSU","url":"https://stock-news.laohu8.com/highlight/detail?id=2528963660","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528963660?lang=en_us&edition=fundamental","pubTime":"2025-04-18 23:34","pubTimestamp":1744990440,"startTime":"0","endTime":"0","summary":"Regeneron Pharmaceuticals and Sanofi won U.S. Food and Drug Administration expanded approval of their blockbuster anti-inflammatory drug Dupixent for the inflammatory skin condition chronic spontaneous urticaria, or CSU.Regeneron and Sanofi on Friday said the approval covers Dupixent in people 12 and older who have CSU and remain symptomatic despite histamine-1 antihistamine treatment.The companies said the green light makes Dupixent the first targeted therapy for CSU in more than a decade, adding that CSU is the seventh disease with underlying type 2 inflammation for which Dupixent is approved.Tarrytown, N.Y., biotechnology company Regeneron created Dupixent and markets it jointly in the U.S. with France's Sanofi under a 2007 collaboration agreement, while Sanofi markets the drug internationally. Dupixent global net sales topped $14 billion last year.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2106854487.HKD","LU0289739699.SGD","REGN","BK4007","LU2362541513.USD","LU1974910355.USD","BK4139","LU0320765992.SGD","SNYNF","LU0053666078.USD","LU1917777945.USD","LU2089984988.USD","LU2237438978.USD","LU2362540622.SGD","BK4585","BK4588","LU2362541273.HKD","LU0823416689.USD","SNY","LU0109394709.USD","LU0058720904.USD","LU0882574055.USD","LU2468319806.SGD","LU0114720955.EUR","LU0889565916.HKD","LU2023250504.SGD","IE00BFXG1179.USD"],"gpt_icon":0},{"id":"2528609578","title":"Sanofi-Regeneron's Dupixent gets FDA's nod for skin condition","url":"https://stock-news.laohu8.com/highlight/detail?id=2528609578","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528609578?lang=en_us&edition=fundamental","pubTime":"2025-04-18 23:26","pubTimestamp":1744990000,"startTime":"0","endTime":"0","summary":"Sanofi-Regeneron's Dupixent gets FDA's nod for skin conditionApril 18  - The U.S. Food and Drug Administration approved the extended use of Sanofi SASY.PA and Regeneron's REGN.O blockbuster drug Dupixent for patients with a type of skin condition, the two companies said on Friday.  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250418:nL1N3QW094:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2089984988.USD","REGN","LU1917777945.USD","LU0058720904.USD","LU1974910355.USD","LU0882574055.USD","BK4588","LU2468319806.SGD","LU2023250504.SGD","LU0109394709.USD","LU0320765992.SGD","LU0823416689.USD","BK4139","LU2106854487.HKD","BK4585","LU2362541513.USD","LU0889565916.HKD","LU2362540622.SGD","LU2237438978.USD","LU0053666078.USD","LU0114720955.EUR","LU0289739699.SGD","LU2362541273.HKD"],"gpt_icon":0},{"id":"2528096277","title":"Press Release: Dupixent approved in the US as the first new targeted therapy in over a decade for chronic spontaneous urticaria","url":"https://stock-news.laohu8.com/highlight/detail?id=2528096277","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528096277?lang=en_us&edition=fundamental","pubTime":"2025-04-18 23:15","pubTimestamp":1744989300,"startTime":"0","endTime":"0","summary":"Dupixent approved in the US as the first new targeted therapy in over a decade for chronic spontaneous urticaria. Approval based on phase 3 studies demonstrating Dupixent significantly reduced itch and hives compared to placebo. In the US, there are more than 300,000 adults and adolescents aged 12 years and older living with CSU who remain symptomatic despite antihistamine treatment. CSU is the seventh disease with underlying type 2 inflammation in which Dupixent is approved. Paris and Tarrytown, NY, April 18, 2025. The US Food and Drug Administration  has approved Dupixent  for the treatment of adults and adolescents aged 12 years and older with chronic spontaneous urticaria  who remain symptomatic despite histamine-1  antihistamine treatment.Kenneth MendezPresident and Chief Executive Officer at the Asthma and Allergy Foundation of America“People with chronic spontaneous urticaria experience sudden, unpredictable hives and severe itch that cause a significant, and often overwhelming,","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/press-release-dupixent-approved-us-151500435.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2106854487.HKD","LU0289739699.SGD","REGN","BK4007","LU2362541513.USD","LU1974910355.USD","BK4139","LU0320765992.SGD","LU0053666078.USD","LU1917777945.USD","LU2089984988.USD","LU2237438978.USD","LU2362540622.SGD","BK4585","BK4588","LU2362541273.HKD","LU0823416689.USD","SNY","LU0109394709.USD","LU0058720904.USD","LU0882574055.USD","LU2468319806.SGD","LU0114720955.EUR","LU0889565916.HKD","LU2023250504.SGD","IE00BFXG1179.USD"],"gpt_icon":0},{"id":"2528096229","title":"Dupixent® (dupilumab) Approved in the U.S. as the First New Targeted Therapy in Over a Decade for Chronic Spontaneous Urticaria (CSU)","url":"https://stock-news.laohu8.com/highlight/detail?id=2528096229","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528096229?lang=en_us&edition=fundamental","pubTime":"2025-04-18 23:15","pubTimestamp":1744989300,"startTime":"0","endTime":"0","summary":"Approval based on Phase 3 trials demonstrating Dupixent significantly reduced itch and hives compared to placebo. In the U.S., there are more than 300,000 adults and adolescents aged 12 years and older living with CSU who remain symptomatic despite antihistamine treatment. CSU is the seventh disease with underlying type 2 inflammation in which Dupixent is approved. The U.S. approval is based on data from two Phase 3 clinical trials, Study A  and Study C , which included biologic-nave patients aged 12 years and older who were symptomatic despite the use of antihistamines and assessed Dupixent as an add-on therapy to standard-of-care antihistamines, compared to antihistamines alone. Both trials met their primary and key secondary endpoints with Dupixent demonstrating reductions in itch severity and urticaria activity  compared to placebo at 24 weeks. Dupixent also increased the likelihood of well-controlled disease or complete response compared to placebo at 24 weeks. Study B  provided a","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/dupixent-dupilumab-approved-u-first-151500962.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0058720904.USD","LU2023250504.SGD","LU2089984988.USD","LU2362541513.USD","PN","LU2237438978.USD","BK4139","LU0114720955.EUR","SNY","BK4007","BK4588","LU0320765992.SGD","REGN","BK4585","LU2362540622.SGD","LU0823416689.USD","LU0109394709.USD","BK4096","LU2362541273.HKD","LU0289739699.SGD","IE00BFXG1179.USD","LU0882574055.USD","LU1917777945.USD","LU2468319806.SGD","UAE","LU1974910355.USD","LU0889565916.HKD","LU0053666078.USD","LU2106854487.HKD"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":2,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/REGN\",params:#limit:5,,,undefined,":[{"date":"2025-04-29","symbol":"REGN","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2025/03","expectedEps":7,"defaultRemindTime":1745913600000,"name":null,"time":"Pre-Market","dateTimestamp":1745899200000,"actualEps":null},{"date":"2025-02-20","symbol":"REGN","amount":0.88,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-02-20","defaultRemindTime":1740061800000,"name":"再生元制药公司","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-20","payableDate":"2025-02-20","currency":"USD","dateTimestamp":1740027600000,"payDate":"2025-03-20"},{"market":"US","date":"2025-02-04","symbol":"REGN","fiscalQuarterEnding":"2024/12","expectedEps":9.62,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1738645200000,"reportTimeType":"pre","actualEps":9.9},{"market":"US","date":"2024-10-31","symbol":"REGN","fiscalQuarterEnding":"2024/09","expectedEps":10.06,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1730347200000,"reportTimeType":"pre","actualEps":11.73},{"market":"US","date":"2024-08-01","symbol":"REGN","fiscalQuarterEnding":"2024/06","expectedEps":8.93,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1722484800000,"reportTimeType":"pre","actualEps":10.1}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"REGN\",market:\"US\",,,undefined,":[{"executeDate":"2025-02-20","recordDate":"2025-02-20","paymentDate":"2025-03-20","value":0.88,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"REGN\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2857,"buy":0.4286,"hold":0.25,"sell":0.0357,"strongSell":0,"meanLabel":"BUY","meanPercent":0.4286,"analysts":28,"updateTime":1742097600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/REGN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"REGN","date":"2025-04-17","current":13.322422,"percent":0.251828,"low":7.447139,"twenty":11.205984,"median":17.137002,"eighty":24.420237,"high":30.763504,"avg":17.641828,"sd":6.262613,"marketCap":58786517328},"quantilePoints":[{"date":"2020-04-24","current":29.801222,"twenty":19.849021,"median":60.209042,"eighty":116.648995,"marketCap":63053425873},{"date":"2020-05-01","current":27.658541,"twenty":19.849021,"median":58.652905,"eighty":116.648995,"marketCap":58519940122},{"date":"2020-05-08","current":27.526215,"twenty":19.849021,"median":57.393234,"eighty":116.585674,"marketCap":62740502883},{"date":"2020-05-15","current":28.176995,"twenty":19.849021,"median":53.421195,"eighty":115.221021,"marketCap":64223824676},{"date":"2020-05-22","current":27.844277,"twenty":19.849021,"median":51.799637,"eighty":114.184286,"marketCap":63465459705},{"date":"2020-05-29","current":27.303609,"twenty":19.849021,"median":51.530268,"eighty":113.633942,"marketCap":62233116768},{"date":"2020-06-05","current":26.599198,"twenty":19.849021,"median":51.349129,"eighty":112.594309,"marketCap":60627552930},{"date":"2020-06-12","current":26.215582,"twenty":19.849021,"median":51.102486,"eighty":112.289501,"marketCap":59753175659},{"date":"2020-06-19","current":28.689708,"twenty":19.849021,"median":50.420041,"eighty":111.71033,"marketCap":65392452064},{"date":"2020-06-26","current":27.239005,"twenty":19.849021,"median":49.850558,"eighty":110.92935,"marketCap":62085863918},{"date":"2020-07-02","current":27.733117,"twenty":19.849021,"median":40.392331,"eighty":110.784746,"marketCap":63212094340},{"date":"2020-07-10","current":27.662275,"twenty":19.849021,"median":31.979399,"eighty":110.206964,"marketCap":63050623973},{"date":"2020-07-17","current":28.695946,"twenty":19.849021,"median":31.36985,"eighty":108.726161,"marketCap":65406669581},{"date":"2020-07-24","current":27.131182,"twenty":19.849021,"median":31.004812,"eighty":106.696094,"marketCap":61840103988},{"date":"2020-07-31","current":28.161734,"twenty":19.849021,"median":30.808341,"eighty":104.408478,"marketCap":64189040838},{"date":"2020-08-07","current":21.875339,"twenty":19.849021,"median":30.656632,"eighty":101.923911,"marketCap":65265075387},{"date":"2020-08-14","current":21.60587,"twenty":19.849021,"median":30.354205,"eighty":101.37008,"marketCap":64461113542},{"date":"2020-08-21","current":21.356152,"twenty":19.849021,"median":30.042238,"eighty":99.974583,"marketCap":63716080837},{"date":"2020-08-28","current":21.254572,"twenty":19.849021,"median":29.867177,"eighty":98.620251,"marketCap":63413016686},{"date":"2020-09-04","current":20.469796,"twenty":19.849021,"median":29.681793,"eighty":97.739726,"marketCap":61071635658},{"date":"2020-09-11","current":19.2138,"twenty":19.673575,"median":29.474412,"eighty":97.336675,"marketCap":57324373708},{"date":"2020-09-18","current":19.583792,"twenty":19.656234,"median":29.203553,"eighty":96.645594,"marketCap":58428242785},{"date":"2020-09-25","current":20.247589,"twenty":19.637789,"median":29.093505,"eighty":95.995591,"marketCap":60408682828},{"date":"2020-10-02","current":19.920981,"twenty":19.637789,"median":28.953278,"eighty":94.856997,"marketCap":59434247398},{"date":"2020-10-09","current":21.235526,"twenty":19.637789,"median":28.860353,"eighty":93.407176,"marketCap":63356192158},{"date":"2020-10-16","current":21.153345,"twenty":19.637789,"median":28.756642,"eighty":89.782622,"marketCap":63111004841},{"date":"2020-10-23","current":20.450397,"twenty":19.637789,"median":28.691316,"eighty":88.348748,"marketCap":61013758824},{"date":"2020-10-30","current":19.171828,"twenty":19.596771,"median":28.536662,"eighty":84.18776,"marketCap":57199149284},{"date":"2020-11-06","current":19.330759,"twenty":19.563112,"median":28.419067,"eighty":80.669454,"marketCap":61007874618},{"date":"2020-11-13","current":18.942826,"twenty":19.391778,"median":28.342989,"eighty":76.671574,"marketCap":59783558673},{"date":"2020-11-20","current":17.347954,"twenty":19.273386,"median":28.194062,"eighty":74.98798,"marketCap":54750142517},{"date":"2020-11-27","current":17.191109,"twenty":19.172764,"median":28.166858,"eighty":74.433116,"marketCap":54255138915},{"date":"2020-12-04","current":16.468751,"twenty":19.105699,"median":28.124531,"eighty":73.576979,"marketCap":51975378191},{"date":"2020-12-11","current":16.0447,"twenty":19.031974,"median":28.045787,"eighty":73.249222,"marketCap":50637074210},{"date":"2020-12-18","current":16.684121,"twenty":18.978847,"median":28.003825,"eighty":72.725467,"marketCap":52655084629},{"date":"2020-12-24","current":16.351033,"twenty":18.951722,"median":27.893932,"eighty":72.508831,"marketCap":51603861628},{"date":"2020-12-31","current":16.156398,"twenty":18.869944,"median":27.783005,"eighty":72.122981,"marketCap":50989592766},{"date":"2021-01-08","current":16.67877,"twenty":18.812345,"median":27.748475,"eighty":71.867927,"marketCap":52638197512},{"date":"2021-01-15","current":17.320865,"twenty":18.741004,"median":27.670408,"eighty":71.690256,"marketCap":54664651490},{"date":"2021-01-22","current":17.984699,"twenty":18.702345,"median":27.64431,"eighty":71.398793,"marketCap":56759709378},{"date":"2021-01-29","current":16.849661,"twenty":18.613885,"median":27.588588,"eighty":71.196483,"marketCap":53177529795},{"date":"2021-02-05","current":14.990488,"twenty":18.469712,"median":27.52903,"eighty":70.956334,"marketCap":52664583632},{"date":"2021-02-12","current":14.395598,"twenty":18.339492,"median":27.404838,"eighty":70.822506,"marketCap":50574613240},{"date":"2021-02-19","current":13.94353,"twenty":18.247865,"median":27.322464,"eighty":70.650351,"marketCap":48986410835},{"date":"2021-02-26","current":13.356584,"twenty":18.183087,"median":27.239458,"eighty":70.34583,"marketCap":46924351319},{"date":"2021-03-05","current":13.682665,"twenty":18.137069,"median":27.131182,"eighty":70.094632,"marketCap":48069939939},{"date":"2021-03-12","current":13.975842,"twenty":18.094122,"median":27.034693,"eighty":69.991059,"marketCap":49099928253},{"date":"2021-03-19","current":14.042244,"twenty":17.992123,"median":26.957419,"eighty":69.774786,"marketCap":49333211754},{"date":"2021-03-26","current":14.1374,"twenty":17.91755,"median":26.838925,"eighty":69.560413,"marketCap":49667515342},{"date":"2021-04-01","current":14.078706,"twenty":17.836459,"median":26.740955,"eighty":69.380807,"marketCap":49461309390},{"date":"2021-04-09","current":14.08582,"twenty":17.582883,"median":26.667813,"eighty":69.047731,"marketCap":49486304051},{"date":"2021-04-16","current":14.898948,"twenty":17.531653,"median":26.603923,"eighty":68.92796,"marketCap":52342985492},{"date":"2021-04-23","current":14.400461,"twenty":17.378502,"median":26.576788,"eighty":68.754213,"marketCap":50591699595},{"date":"2021-04-30","current":14.184148,"twenty":17.314319,"median":26.47571,"eighty":68.667059,"marketCap":49831747330},{"date":"2021-05-07","current":12.848195,"twenty":17.236982,"median":26.416524,"eighty":68.548435,"marketCap":51441604940},{"date":"2021-05-14","current":13.362123,"twenty":17.131868,"median":26.350888,"eighty":68.476599,"marketCap":53499269138},{"date":"2021-05-21","current":13.106065,"twenty":16.947039,"median":26.270161,"eighty":68.395732,"marketCap":52474061510},{"date":"2021-05-28","current":12.995106,"twenty":16.837354,"median":26.029338,"eighty":68.15674,"marketCap":52029804872},{"date":"2021-06-04","current":13.239784,"twenty":16.702149,"median":25.825146,"eighty":68.017841,"marketCap":53009447716},{"date":"2021-06-11","current":13.593093,"twenty":16.634935,"median":25.762014,"eighty":67.890019,"marketCap":54424027129},{"date":"2021-06-18","current":13.913037,"twenty":16.514074,"median":25.58899,"eighty":67.722101,"marketCap":55705018881},{"date":"2021-06-25","current":14.239706,"twenty":16.438175,"median":25.425582,"eighty":67.525077,"marketCap":57012935279},{"date":"2021-07-02","current":15.095563,"twenty":16.378422,"median":25.38134,"eighty":67.387984,"marketCap":60439614106},{"date":"2021-07-09","current":15.011762,"twenty":16.299089,"median":25.245133,"eighty":67.28571,"marketCap":60104091610},{"date":"2021-07-16","current":15.085217,"twenty":16.168829,"median":25.161304,"eighty":66.948314,"marketCap":60398191576},{"date":"2021-07-23","current":15.165656,"twenty":16.140773,"median":25.057563,"eighty":66.699512,"marketCap":60720251750},{"date":"2021-07-30","current":14.862006,"twenty":16.05773,"median":24.844212,"eighty":66.473671,"marketCap":59504500482},{"date":"2021-08-06","current":10.234607,"twenty":15.941934,"median":24.580228,"eighty":66.222266,"marketCap":63509831394},{"date":"2021-08-13","current":10.467996,"twenty":15.811105,"median":24.409963,"eighty":65.572203,"marketCap":64958104241},{"date":"2021-08-20","current":11.112707,"twenty":15.71172,"median":24.133895,"eighty":65.35903,"marketCap":68958789033},{"date":"2021-08-27","current":11.113042,"twenty":15.594292,"median":23.952572,"eighty":64.943681,"marketCap":68960868391},{"date":"2021-09-03","current":11.385804,"twenty":15.416611,"median":23.896291,"eighty":64.163045,"marketCap":70653465803},{"date":"2021-09-10","current":10.898585,"twenty":15.358543,"median":23.822687,"eighty":64.001642,"marketCap":67630079271},{"date":"2021-09-17","current":10.921874,"twenty":15.31188,"median":23.556993,"eighty":63.614678,"marketCap":67774594652},{"date":"2021-09-24","current":10.704401,"twenty":15.216063,"median":23.36376,"eighty":63.039237,"marketCap":66425091310},{"date":"2021-10-01","current":9.563257,"twenty":15.168295,"median":23.248274,"eighty":62.60394,"marketCap":59343837641},{"date":"2021-10-08","current":9.215268,"twenty":15.152615,"median":23.044477,"eighty":62.187301,"marketCap":57184424358},{"date":"2021-10-15","current":9.269217,"twenty":15.096804,"median":22.886718,"eighty":61.909902,"marketCap":57519200996},{"date":"2021-10-22","current":9.589562,"twenty":15.075632,"median":22.781044,"eighty":60.689685,"marketCap":59507067244},{"date":"2021-10-29","current":10.721826,"twenty":15.02843,"median":22.711601,"eighty":58.441572,"marketCap":66533217926},{"date":"2021-11-05","current":9.140146,"twenty":15.010362,"median":22.587367,"eighty":56.983625,"marketCap":63939894320},{"date":"2021-11-12","current":9.433987,"twenty":14.972274,"median":22.403299,"eighty":52.676989,"marketCap":65995456216},{"date":"2021-11-19","current":9.75503,"twenty":14.914028,"median":22.242861,"eighty":51.731325,"marketCap":68241309194},{"date":"2021-11-26","current":9.615582,"twenty":14.873644,"median":22.206358,"eighty":51.46717,"marketCap":67265806015},{"date":"2021-12-03","current":9.493174,"twenty":14.846146,"median":22.027357,"eighty":51.289641,"marketCap":66409496151},{"date":"2021-12-10","current":10.006722,"twenty":14.763396,"median":21.89368,"eighty":50.996878,"marketCap":70002024471},{"date":"2021-12-17","current":9.255829,"twenty":14.645835,"median":21.852902,"eighty":50.192382,"marketCap":64749154191},{"date":"2021-12-23","current":9.347001,"twenty":14.543935,"median":21.806579,"eighty":49.835452,"marketCap":65386942979},{"date":"2021-12-31","current":9.43877,"twenty":14.480705,"median":21.69052,"eighty":32.798336,"marketCap":66028913989},{"date":"2022-01-07","current":9.023417,"twenty":14.400343,"median":21.58144,"eighty":31.955254,"marketCap":63123315560},{"date":"2022-01-14","current":9.195447,"twenty":14.360499,"median":21.468059,"eighty":31.332217,"marketCap":64326749814},{"date":"2022-01-21","current":9.287515,"twenty":14.29746,"median":21.412668,"eighty":31.053495,"marketCap":64970811934},{"date":"2022-01-28","current":9.340125,"twenty":14.271924,"median":21.249665,"eighty":30.821672,"marketCap":65338847431},{"date":"2022-02-04","current":8.06582,"twenty":14.211698,"median":21.155814,"eighty":30.665092,"marketCap":65133918575},{"date":"2022-02-11","current":8.414784,"twenty":14.141195,"median":20.886786,"eighty":30.397746,"marketCap":67951902021},{"date":"2022-02-18","current":8.107934,"twenty":14.100469,"median":20.718789,"eighty":30.063963,"marketCap":65473995536},{"date":"2022-02-25","current":8.154462,"twenty":14.0749,"median":20.630748,"eighty":29.944922,"marketCap":65849726202},{"date":"2022-03-04","current":8.177528,"twenty":14.052898,"median":20.548589,"eighty":29.711783,"marketCap":66035994945},{"date":"2022-03-11","current":8.469748,"twenty":13.990355,"median":20.497058,"eighty":29.510771,"marketCap":68395753827},{"date":"2022-03-18","current":9.041269,"twenty":13.952186,"median":20.431603,"eighty":29.231348,"marketCap":73010961095},{"date":"2022-03-25","current":8.96337,"twenty":13.923409,"median":20.297711,"eighty":29.102336,"marketCap":72381904938},{"date":"2022-04-01","current":9.158447,"twenty":13.87369,"median":20.180575,"eighty":28.966736,"marketCap":73957206312},{"date":"2022-04-08","current":9.738536,"twenty":13.848877,"median":20.056598,"eighty":28.871934,"marketCap":78641599112},{"date":"2022-04-14","current":9.661823,"twenty":13.817339,"median":19.925312,"eighty":28.815517,"marketCap":78022122491},{"date":"2022-04-22","current":9.180836,"twenty":13.785109,"median":19.790673,"eighty":28.696957,"marketCap":74138001167},{"date":"2022-04-29","current":8.794298,"twenty":13.737566,"median":19.660289,"eighty":28.556678,"marketCap":71016593927},{"date":"2022-05-06","current":8.46164,"twenty":13.72215,"median":19.591904,"eighty":28.472288,"marketCap":67131266171},{"date":"2022-05-13","current":8.766805,"twenty":13.695689,"median":19.451906,"eighty":28.362701,"marketCap":69552323150},{"date":"2022-05-20","current":8.97894,"twenty":13.651777,"median":19.315239,"eighty":28.201625,"marketCap":71235318701},{"date":"2022-05-27","current":9.408914,"twenty":13.61647,"median":19.182482,"eighty":28.169777,"marketCap":74646563203},{"date":"2022-06-03","current":8.560781,"twenty":13.580763,"median":19.147609,"eighty":28.138912,"marketCap":67917813387},{"date":"2022-06-10","current":7.76575,"twenty":13.496152,"median":19.040029,"eighty":28.05351,"marketCap":61610351191},{"date":"2022-06-17","current":7.88988,"twenty":13.458929,"median":18.983291,"eighty":28.012848,"marketCap":62595151404},{"date":"2022-06-24","current":8.318225,"twenty":13.394252,"median":18.968689,"eighty":27.917096,"marketCap":65993466363},{"date":"2022-07-01","current":8.086125,"twenty":13.329334,"median":18.871653,"eighty":27.782289,"marketCap":64152083907},{"date":"2022-07-08","current":8.44154,"twenty":13.241565,"median":18.818752,"eighty":27.753004,"marketCap":66971801804},{"date":"2022-07-15","current":8.250999,"twenty":13.112583,"median":18.780003,"eighty":27.691117,"marketCap":65460122702},{"date":"2022-07-22","current":7.959958,"twenty":13.007521,"median":18.702505,"eighty":27.643858,"marketCap":63151121765},{"date":"2022-07-29","current":7.89993,"twenty":12.891389,"median":18.620106,"eighty":27.587706,"marketCap":62674883587},{"date":"2022-08-05","current":11.535488,"twenty":11.550716,"median":18.471047,"eighty":27.528467,"marketCap":65600015462},{"date":"2022-08-12","current":11.819359,"twenty":11.550716,"median":18.341073,"eighty":27.404209,"marketCap":67214331124},{"date":"2022-08-19","current":11.624785,"twenty":11.550716,"median":18.231129,"eighty":27.303428,"marketCap":66107829991},{"date":"2022-08-26","current":11.207815,"twenty":11.371909,"median":18.181433,"eighty":27.225906,"marketCap":63736603409},{"date":"2022-09-02","current":10.915297,"twenty":11.30967,"median":18.134856,"eighty":27.121826,"marketCap":62073109919},{"date":"2022-09-09","current":13.616768,"twenty":11.259308,"median":18.095368,"eighty":27.037827,"marketCap":77435835791},{"date":"2022-09-16","current":13.353201,"twenty":11.259308,"median":17.997073,"eighty":26.966349,"marketCap":75936981116},{"date":"2022-09-23","current":13.109373,"twenty":11.259308,"median":17.919992,"eighty":26.835951,"marketCap":74550380180},{"date":"2022-09-30","current":12.95033,"twenty":11.259308,"median":17.763862,"eighty":26.722775,"marketCap":73645935776},{"date":"2022-10-07","current":13.580109,"twenty":11.259308,"median":17.582147,"eighty":26.649626,"marketCap":77227364563},{"date":"2022-10-14","current":13.837473,"twenty":11.259308,"median":17.514489,"eighty":26.601993,"marketCap":78690939491},{"date":"2022-10-21","current":13.421066,"twenty":11.259308,"median":17.357987,"eighty":26.567778,"marketCap":76322920159},{"date":"2022-10-28","current":14.113824,"twenty":11.259308,"median":17.305502,"eighty":26.472046,"marketCap":80262491824},{"date":"2022-11-04","current":14.720939,"twenty":11.259308,"median":17.230044,"eighty":26.401701,"marketCap":79055860306},{"date":"2022-11-11","current":14.606387,"twenty":11.259308,"median":17.119207,"eighty":26.346411,"marketCap":78440681160},{"date":"2022-11-18","current":14.651731,"twenty":11.259308,"median":16.930926,"eighty":26.239227,"marketCap":78684189572},{"date":"2022-11-25","current":14.641787,"twenty":11.259308,"median":16.849661,"eighty":26.033735,"marketCap":78630788605},{"date":"2022-12-02","current":15.241595,"twenty":11.259308,"median":16.684121,"eighty":25.823128,"marketCap":81851934964},{"date":"2022-12-09","current":14.916831,"twenty":11.259308,"median":16.625596,"eighty":25.738839,"marketCap":80107859366},{"date":"2022-12-16","current":14.382056,"twenty":11.259308,"median":16.468751,"eighty":25.567197,"marketCap":77235955333},{"date":"2022-12-23","current":14.453054,"twenty":11.259308,"median":16.426279,"eighty":25.414911,"marketCap":77617238241},{"date":"2022-12-30","current":14.348645,"twenty":11.259308,"median":16.386349,"eighty":25.384384,"marketCap":77056528083},{"date":"2023-01-06","current":14.660083,"twenty":11.259308,"median":16.317075,"eighty":25.250581,"marketCap":78729046385},{"date":"2023-01-13","current":14.361373,"twenty":11.259308,"median":16.169536,"eighty":25.174538,"marketCap":77124881321},{"date":"2023-01-20","current":14.358788,"twenty":11.259308,"median":16.151382,"eighty":25.098264,"marketCap":77110997070},{"date":"2023-01-27","current":14.773045,"twenty":11.259308,"median":16.092523,"eighty":24.875579,"marketCap":79335681376},{"date":"2023-02-03","current":19.278951,"twenty":11.259308,"median":15.99554,"eighty":24.688912,"marketCap":83639799356},{"date":"2023-02-10","current":18.637362,"twenty":11.259308,"median":15.99554,"eighty":24.479131,"marketCap":80856330298},{"date":"2023-02-17","current":18.419158,"twenty":11.259308,"median":15.99554,"eighty":24.334872,"marketCap":79909674829},{"date":"2023-02-24","current":18.62211,"twenty":11.259308,"median":15.99554,"eighty":24.08253,"marketCap":80790160468},{"date":"2023-03-03","current":19.17094,"twenty":11.259308,"median":15.99554,"eighty":23.912342,"marketCap":83171207087},{"date":"2023-03-10","current":18.376354,"twenty":11.259308,"median":15.99554,"eighty":23.83133,"marketCap":79723972404},{"date":"2023-03-17","current":18.392344,"twenty":11.259308,"median":15.99554,"eighty":23.634714,"marketCap":79793343999},{"date":"2023-03-24","current":20.172169,"twenty":11.259308,"median":15.99554,"eighty":23.395584,"marketCap":87514936240},{"date":"2023-03-31","current":20.213251,"twenty":11.270868,"median":16.006911,"eighty":23.269698,"marketCap":87693167878},{"date":"2023-04-06","current":20.300582,"twenty":11.270868,"median":16.006911,"eighty":23.16464,"marketCap":88072043517},{"date":"2023-04-14","current":20.426781,"twenty":11.259308,"median":15.99554,"eighty":22.981137,"marketCap":88619545496},{"date":"2023-04-21","current":19.633424,"twenty":11.259308,"median":15.99554,"eighty":22.826311,"marketCap":85177647089},{"date":"2023-04-28","current":19.560756,"twenty":11.259308,"median":15.99554,"eighty":22.744778,"marketCap":84862383141},{"date":"2023-05-05","current":19.3053,"twenty":11.259308,"median":15.99554,"eighty":22.693077,"marketCap":80748278285},{"date":"2023-05-12","current":19.092498,"twenty":11.247747,"median":15.988674,"eighty":22.679792,"marketCap":79858192074},{"date":"2023-05-19","current":19.141409,"twenty":11.247747,"median":15.988674,"eighty":22.52179,"marketCap":80062772659},{"date":"2023-05-26","current":18.565743,"twenty":11.247747,"median":15.988674,"eighty":22.52179,"marketCap":77654934150},{"date":"2023-06-02","current":18.723744,"twenty":11.247747,"median":15.988674,"eighty":22.416292,"marketCap":78315804417},{"date":"2023-06-09","current":19.209014,"twenty":11.247747,"median":15.988674,"eighty":22.202364,"marketCap":80345543730},{"date":"2023-06-16","current":20.052795,"twenty":11.247747,"median":15.988674,"eighty":21.930123,"marketCap":83874826599},{"date":"2023-06-23","current":19.969313,"twenty":11.236187,"median":15.981807,"eighty":21.872257,"marketCap":83525647171},{"date":"2023-06-30","current":18.141164,"twenty":11.224626,"median":15.96462,"eighty":21.812599,"marketCap":75879046138},{"date":"2023-07-07","current":18.049231,"twenty":11.224626,"median":15.96462,"eighty":21.69052,"marketCap":75494520326},{"date":"2023-07-14","current":18.462799,"twenty":11.224626,"median":15.96462,"eighty":21.546615,"marketCap":77224350928},{"date":"2023-07-21","current":18.51504,"twenty":11.224626,"median":15.96462,"eighty":21.443977,"marketCap":77442855847},{"date":"2023-07-28","current":19.069195,"twenty":11.224626,"median":15.96462,"eighty":21.26942,"marketCap":79760721743},{"date":"2023-08-04","current":19.014155,"twenty":11.224626,"median":15.96462,"eighty":21.191438,"marketCap":81741853001},{"date":"2023-08-11","current":19.545551,"twenty":11.224626,"median":15.96462,"eighty":20.904333,"marketCap":84026322961},{"date":"2023-08-18","current":19.637239,"twenty":11.224626,"median":15.96462,"eighty":20.742089,"marketCap":84420489392},{"date":"2023-08-25","current":20.487077,"twenty":11.224626,"median":15.96462,"eighty":20.708932,"marketCap":88073945988},{"date":"2023-09-01","current":20.370742,"twenty":11.224626,"median":15.96462,"eighty":20.579258,"marketCap":87573820839},{"date":"2023-09-08","current":20.340426,"twenty":11.224626,"median":15.96462,"eighty":20.556869,"marketCap":87443491616},{"date":"2023-09-15","current":20.515915,"twenty":11.224626,"median":15.96462,"eighty":20.525527,"marketCap":88197917688},{"date":"2023-09-22","current":20.294089,"twenty":11.224626,"median":15.96462,"eighty":20.503675,"marketCap":87244289226},{"date":"2023-09-29","current":20.569892,"twenty":11.224626,"median":15.96462,"eighty":20.497429,"marketCap":88429967281},{"date":"2023-10-06","current":20.484859,"twenty":11.224626,"median":15.96462,"eighty":20.47919,"marketCap":88064409704},{"date":"2023-10-13","current":20.66651,"twenty":11.224626,"median":15.96462,"eighty":20.47919,"marketCap":88845325455},{"date":"2023-10-20","current":19.930788,"twenty":11.224626,"median":15.96462,"eighty":20.469796,"marketCap":85682457723},{"date":"2023-10-27","current":19.520904,"twenty":11.217472,"median":15.933685,"eighty":20.452301,"marketCap":83920364243},{"date":"2023-11-03","current":21.737851,"twenty":11.217472,"median":15.933685,"eighty":20.408361,"marketCap":86757938711},{"date":"2023-11-10","current":21.323755,"twenty":11.217472,"median":15.933685,"eighty":20.408361,"marketCap":85105237415},{"date":"2023-11-17","current":21.224631,"twenty":11.217472,"median":15.933685,"eighty":20.421192,"marketCap":84709626635},{"date":"2023-11-24","current":21.271528,"twenty":11.217472,"median":15.933685,"eighty":20.452301,"marketCap":84896797327},{"date":"2023-12-01","current":21.951269,"twenty":11.217472,"median":15.933685,"eighty":20.452301,"marketCap":87609708889},{"date":"2023-12-08","current":22.627279,"twenty":11.219857,"median":15.940559,"eighty":20.455788,"marketCap":90307731873},{"date":"2023-12-15","current":23.341925,"twenty":11.219857,"median":15.940559,"eighty":20.455788,"marketCap":93159957984},{"date":"2023-12-22","current":22.432763,"twenty":11.217472,"median":15.933685,"eighty":20.452301,"marketCap":89531398889},{"date":"2023-12-29","current":23.493808,"twenty":11.215088,"median":15.919407,"eighty":20.445674,"marketCap":93766135792},{"date":"2024-01-05","current":24.305712,"twenty":11.212703,"median":15.905129,"eighty":20.426781,"marketCap":97006528395},{"date":"2024-01-12","current":24.406967,"twenty":11.212703,"median":15.905129,"eighty":20.426781,"marketCap":97410646934},{"date":"2024-01-19","current":24.780811,"twenty":11.212541,"median":15.891644,"eighty":20.415603,"marketCap":98902695120},{"date":"2024-01-26","current":25.283622,"twenty":11.212703,"median":15.905129,"eighty":20.426781,"marketCap":100909462708},{"date":"2024-02-02","current":25.521038,"twenty":11.212703,"median":15.905129,"eighty":20.426781,"marketCap":101857014335},{"date":"2024-02-09","current":25.724697,"twenty":11.212703,"median":15.905129,"eighty":20.459114,"marketCap":101705162231},{"date":"2024-02-16","current":25.950297,"twenty":11.212703,"median":15.905129,"eighty":20.47919,"marketCap":102597095968},{"date":"2024-02-23","current":26.226454,"twenty":11.212703,"median":15.905129,"eighty":20.497429,"marketCap":103688908831},{"date":"2024-03-01","current":26.259071,"twenty":11.215088,"median":15.919407,"eighty":20.518368,"marketCap":103817863106},{"date":"2024-03-08","current":26.455316,"twenty":11.215088,"median":15.919407,"eighty":20.545637,"marketCap":104593737995},{"date":"2024-03-15","current":26.067447,"twenty":11.215088,"median":15.919407,"eighty":20.571273,"marketCap":103060256739},{"date":"2024-03-22","current":26.311258,"twenty":11.215088,"median":15.919407,"eighty":20.621194,"marketCap":104024189946},{"date":"2024-03-28","current":26.264779,"twenty":11.215088,"median":15.919407,"eighty":20.655603,"marketCap":103840430104},{"date":"2024-04-05","current":25.468926,"twenty":11.212703,"median":15.905129,"eighty":20.723691,"marketCap":100693945789},{"date":"2024-04-12","current":25.015007,"twenty":11.212703,"median":15.905129,"eighty":20.904157,"marketCap":98899332126},{"date":"2024-04-19","current":24.299337,"twenty":11.212703,"median":15.947434,"eighty":21.122307,"marketCap":96069860405},{"date":"2024-04-26","current":24.304801,"twenty":11.215088,"median":16.055559,"eighty":21.212036,"marketCap":96091459812},{"date":"2024-05-03","current":26.22078,"twenty":11.215088,"median":16.138956,"eighty":21.263447,"marketCap":101154526467},{"date":"2024-05-10","current":27.070653,"twenty":11.215088,"median":16.168653,"eighty":21.31672,"marketCap":104433166904},{"date":"2024-05-17","current":27.070094,"twenty":11.215088,"median":16.294592,"eighty":21.377367,"marketCap":104431009193},{"date":"2024-05-24","current":27.42218,"twenty":11.215088,"median":16.403186,"eighty":21.543145,"marketCap":105789287676},{"date":"2024-05-31","current":27.124068,"twenty":11.215088,"median":16.446392,"eighty":21.604318,"marketCap":104639228214},{"date":"2024-06-07","current":27.987644,"twenty":11.215088,"median":16.556015,"eighty":21.765364,"marketCap":107970732547},{"date":"2024-06-14","current":28.708036,"twenty":11.212703,"median":16.641161,"eighty":21.875339,"marketCap":110749863104},{"date":"2024-06-21","current":29.206942,"twenty":11.212541,"median":16.702347,"eighty":21.926914,"marketCap":112674540478},{"date":"2024-06-28","current":29.387879,"twenty":11.212055,"median":16.849661,"eighty":22.012139,"marketCap":113372559682},{"date":"2024-07-05","current":28.639241,"twenty":11.212055,"median":16.930926,"eighty":22.201171,"marketCap":110484464767},{"date":"2024-07-12","current":30.210346,"twenty":11.212055,"median":17.140309,"eighty":22.42349,"marketCap":116545472325},{"date":"2024-07-15","current":30.763504,"twenty":11.212055,"median":17.191109,"eighty":22.533173,"marketCap":118679447575},{"date":"2024-08-02","current":27.30119,"twenty":11.206899,"median":17.301169,"eighty":22.615128,"marketCap":117987551031},{"date":"2024-08-09","current":27.805935,"twenty":11.206899,"median":17.352971,"eighty":22.804619,"marketCap":120168907862},{"date":"2024-08-16","current":29.353886,"twenty":11.206899,"median":17.547174,"eighty":23.185349,"marketCap":126858689969},{"date":"2024-08-23","current":29.661828,"twenty":11.206899,"median":17.668241,"eighty":23.520288,"marketCap":128189522712},{"date":"2024-08-30","current":29.443796,"twenty":11.206899,"median":17.89624,"eighty":23.992786,"marketCap":127247254273},{"date":"2024-09-06","current":28.735255,"twenty":11.206899,"median":18.004331,"eighty":24.127024,"marketCap":124185151686},{"date":"2024-09-13","current":29.082408,"twenty":11.206899,"median":18.146003,"eighty":24.305165,"marketCap":125685441639},{"date":"2024-09-20","current":28.726014,"twenty":11.206899,"median":18.30367,"eighty":24.388542,"marketCap":124145215910},{"date":"2024-09-27","current":25.973018,"twenty":11.206899,"median":18.360535,"eighty":24.456418,"marketCap":112247592778},{"date":"2024-10-04","current":25.339402,"twenty":11.206899,"median":18.388792,"eighty":24.700046,"marketCap":109509293778},{"date":"2024-10-11","current":24.950541,"twenty":11.206899,"median":18.407637,"eighty":24.906035,"marketCap":107828753161},{"date":"2024-10-18","current":24.930811,"twenty":11.206899,"median":18.470866,"eighty":25.028446,"marketCap":107743484883},{"date":"2024-10-25","current":23.199293,"twenty":11.206899,"median":18.52949,"eighty":25.028446,"marketCap":100260383988},{"date":"2024-10-31","current":23.046696,"twenty":11.206899,"median":18.566384,"eighty":25.028446,"marketCap":99600904015},{"date":"2024-11-08","current":19.05799,"twenty":11.206442,"median":18.637362,"eighty":25.035165,"marketCap":88705416518},{"date":"2024-11-15","current":18.087847,"twenty":11.206442,"median":18.657932,"eighty":25.035165,"marketCap":84189883902},{"date":"2024-11-22","current":17.20924,"twenty":11.206442,"median":18.657932,"eighty":25.035165,"marketCap":80100405829},{"date":"2024-11-29","current":17.341458,"twenty":11.206442,"median":18.64179,"eighty":25.035165,"marketCap":80715817946},{"date":"2024-12-06","current":17.750134,"twenty":11.206442,"median":18.605435,"eighty":25.035165,"marketCap":82618000854},{"date":"2024-12-13","current":17.127643,"twenty":11.206442,"median":18.54394,"eighty":25.035165,"marketCap":79720614785},{"date":"2024-12-20","current":16.371315,"twenty":11.206442,"median":18.478932,"eighty":25.035165,"marketCap":76200285330},{"date":"2024-12-27","current":16.566176,"twenty":11.206442,"median":18.419158,"eighty":25.035165,"marketCap":77107265077},{"date":"2025-01-03","current":16.531734,"twenty":11.206442,"median":18.397243,"eighty":25.035165,"marketCap":76946956675},{"date":"2025-01-10","current":16.957053,"twenty":11.205984,"median":18.379244,"eighty":25.041885,"marketCap":78926604046},{"date":"2025-01-17","current":16.024125,"twenty":11.205984,"median":18.326784,"eighty":25.041885,"marketCap":74584290575},{"date":"2025-01-24","current":16.056718,"twenty":11.205984,"median":18.268644,"eighty":25.041885,"marketCap":74735991813},{"date":"2025-01-31","current":15.789506,"twenty":11.205984,"median":18.268644,"eighty":25.041885,"marketCap":73492256835},{"date":"2025-02-07","current":17.513328,"twenty":11.205984,"median":18.205402,"eighty":25.041885,"marketCap":77279312131},{"date":"2025-02-14","current":16.353971,"twenty":11.205984,"median":18.068539,"eighty":25.041885,"marketCap":72163532332},{"date":"2025-02-21","current":16.881503,"twenty":11.205984,"median":17.989927,"eighty":25.041885,"marketCap":74491319165},{"date":"2025-02-28","current":17.045462,"twenty":11.205984,"median":17.861315,"eighty":25.041885,"marketCap":75214806015},{"date":"2025-03-07","current":16.940198,"twenty":11.205526,"median":17.547284,"eighty":24.953276,"marketCap":74750318896},{"date":"2025-03-14","current":16.507743,"twenty":11.205526,"median":17.434844,"eighty":24.953276,"marketCap":72842068816},{"date":"2025-03-21","current":16.071408,"twenty":11.205526,"median":17.347954,"eighty":24.876365,"marketCap":70916694786},{"date":"2025-03-28","current":15.421634,"twenty":11.205526,"median":17.320865,"eighty":24.876365,"marketCap":68049503556},{"date":"2025-04-04","current":14.810668,"twenty":11.205526,"median":17.220578,"eighty":24.757629,"marketCap":65353551816},{"date":"2025-04-11","current":13.252327,"twenty":11.205984,"median":17.191443,"eighty":24.571362,"marketCap":58477215997},{"date":"2025-04-17","current":13.322422,"twenty":11.205984,"median":17.137002,"eighty":24.420237,"marketCap":58786517328}],"updateTime":1745302633051}}}